
Summary
This Science Weekly episode explores the growing trend of women using testosterone therapy, particularly for menopausal symptoms. The discussion covers the evidence for testosterone's effectiveness, safety concerns, and the challenges women face accessing appropriate treatments.
Insights
- There's no evidence that testosterone levels drop meaningfully during natural menopause, contrary to popular belief
- Blood testosterone tests are unreliable predictors of symptoms in women due to extremely low levels and cellular conversion differences
- Testosterone therapy has proven effectiveness only for low libido in postmenopausal women, not other claimed benefits
- Women's healthcare gaps drive patients to seek unregulated treatments when NHS access is limited
- High demand for testosterone therapy among women has created a market for private and potentially unsafe sources
Trends
1000% increase in NHS testosterone gel prescriptions for women aged 50+ between 2015-2022Growing trend of women seeking testosterone therapy for menopausal symptoms beyond libidoIncreased private healthcare usage when NHS menopause clinic waiting lists are longRising influence of social media and reality TV in promoting hormone therapiesWomen turning to unregulated testosterone sources due to access barriersGrowing acceptance of testosterone research in women's healthcare after decades of neglect
Topics
Testosterone therapy for womenMenopause treatment optionsHormone replacement therapy (HRT)Women's healthcare access barriersNHS prescription trendsPerimenopause symptomsFemale libido treatmentHormone testing accuracyPrivate healthcare demandUnregulated medication risksClinical trial research gapsEndocrinologyWomen's health research funding
Companies
Sleep Number
Advertiser promoting smart beds with personalized comfort settings and President's Day sale
Whole Foods Market
Advertiser promoting game day food products and prepared foods department offerings
NHS
Primary healthcare provider showing 1000% increase in women's testosterone prescriptions
Medicines and Healthcare Products Regulatory Agency
UK regulator that approved first female-specific testosterone formulation in 2023
The Guardian
Publisher of the podcast and employer of science journalist Linda Geddes
Monash University
Academic institution where Professor Susan Davis heads the Women's Health Research Program
People
Madeline Finlay
Host and producer of the Science Weekly podcast episode on women and testosterone
Linda Geddes
Guardian science journalist who shared her personal experience with testosterone therapy
Professor Susan Davis
Monash University endocrinologist and leading researcher on testosterone in women
Joel Cox
Sound designer for the Science Weekly podcast episode
Ellie Burie
Executive producer of the Science Weekly podcast
Quotes
"There is very good, consistent, repeatable evidence that in postmenopausal women and testosterone can improve libido in the majority of women with low libido."
Professor Susan Davis
"We don't know that the testosterone production changes after menopause because so far not a single study has shown that testosterone levels drop meaningfully during natural menopause."
Professor Susan Davis
"Based on my experience, if you're expecting testosterone to have a big impact on your mood, on your brain fog, you're going to be disappointed."
Linda Geddes
"It's like trying to use a yardstick to measure millimeters under a microscope."
Professor Susan Davis
Full Transcript
5 Speakers